Be the cure
Be the cure
Be the
Change a life
Change a life
Change a
Join our team
Join our team
Join our

The expertise to create cures and life-changing treatments

Assembly Bio is passionately applying scientific ingenuity, and a deep knowledge of virology to find a cure for hepatitis B (HBV), one of the world’s most prevalent and devastating infectious diseases. At the same time, we are advancing a microbiome portfolio of live biotherapeutics capable of transforming lives in a broad range of tough-to-treat conditions. Be a part of our ambitious and caring life’s work. Together, we have the potential to change lives.

In the News
August 05, 2020
Assembly Biosciences Reports Second Quarter 2020 Financial Results and Recent Highlights
July 20, 2020
Assembly Biosciences and BeiGene Announce License and Collaboration Agreement in China for Assembly’s Portfolio of Three Clinical-Stage Core Inhibitors for Chronic Hepatitis B Infection
July 09, 2020
Assembly Biosciences Announces FDA Fast Track Designation Granted to ABI-H2158 for the Treatment of Chronic Hepatitis B Virus Infection
    Tech in lab

    It’s time to end the deadly Hepatitis B virus that has killed more than 800,000 people a year, including my own family members. I’m encouraged by the efforts of Assembly Bio to develop better treatments that could lead to a cure.”

    — Alan Wang, Emmy award-winning television news anchor.
    Infected at birth with chronic Hepatitis B.